BR112022018028A2 - Ácido hialurônico reticulado e composição de carga - Google Patents

Ácido hialurônico reticulado e composição de carga

Info

Publication number
BR112022018028A2
BR112022018028A2 BR112022018028A BR112022018028A BR112022018028A2 BR 112022018028 A2 BR112022018028 A2 BR 112022018028A2 BR 112022018028 A BR112022018028 A BR 112022018028A BR 112022018028 A BR112022018028 A BR 112022018028A BR 112022018028 A2 BR112022018028 A2 BR 112022018028A2
Authority
BR
Brazil
Prior art keywords
hyaluronic acid
recticulated
load composition
composition
load
Prior art date
Application number
BR112022018028A
Other languages
English (en)
Inventor
Soo Lim Cheon
Ho Cho Jung
Cheol Yang Jong
Hoon Rhee Chang
Original Assignee
Medytox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medytox Inc filed Critical Medytox Inc
Publication of BR112022018028A2 publication Critical patent/BR112022018028A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ÁCIDO HIALURÔNICO RETICULADO E COMPOSIÇÃO DE CARGA. São fornecidos um ácido hialurônico reticulado e o uso do mesmo.
BR112022018028A 2020-03-10 2021-02-17 Ácido hialurônico reticulado e composição de carga BR112022018028A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200029805A KR102395184B1 (ko) 2020-03-10 2020-03-10 단일상도 아니고 이성상도 아닌 히알루론산 가교체, 및 이의 용도
PCT/KR2021/001989 WO2021182763A1 (ko) 2020-03-10 2021-02-17 히알루론산 가교체, 및 이의 용도

Publications (1)

Publication Number Publication Date
BR112022018028A2 true BR112022018028A2 (pt) 2022-11-01

Family

ID=77670759

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018028A BR112022018028A2 (pt) 2020-03-10 2021-02-17 Ácido hialurônico reticulado e composição de carga

Country Status (7)

Country Link
US (1) US20230126726A1 (pt)
EP (1) EP4119585A4 (pt)
JP (1) JP7480331B2 (pt)
KR (1) KR102395184B1 (pt)
CN (1) CN115279798A (pt)
BR (1) BR112022018028A2 (pt)
WO (1) WO2021182763A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023075350A1 (ko) * 2021-10-25 2023-05-04 바이오플러스 주식회사 가교 히알루론산을 포함하는 가슴 보형물 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130010973A (ko) * 2011-07-20 2013-01-30 (주)메디톡스 가교 히알루론산 겔의 제조 방법
KR101869988B1 (ko) * 2013-03-27 2018-06-21 주식회사 엘지화학 점탄성 히알루론산 가교물 제조용 조성물, 및 이를 이용하여 얻은 히알루론산 가교물
FR3006689A1 (fr) * 2013-06-11 2014-12-12 Benedicte Vincente Tauzin Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu
US20150283080A1 (en) * 2014-04-03 2015-10-08 Pankaj Modi Stabilized dermatological delivery system for active ingredient compositions for topical administration to the skin
KR101720426B1 (ko) * 2015-09-01 2017-04-14 (주)시지바이오 히알루론산 조성물 및 그의 제조방법
KR101660211B1 (ko) 2016-06-07 2016-09-26 동국제약 주식회사 단일상과 이성상의 특성을 동시에 갖는 히알루론산 가교체, 이의 제조 방법 및 이의 용도
JP6853375B2 (ja) * 2017-02-28 2021-03-31 シージー バイオ カンパニー，リミテッド 皮膚注入用組成物
CN108250457A (zh) * 2017-05-08 2018-07-06 上海利康瑞生物工程有限公司 一种剪切粘度可控的双相交联透明质酸钠凝胶及其制备方法和制剂
KR102320153B1 (ko) * 2017-11-23 2021-11-02 주식회사 파마리서치 이중 가교를 통한 히알루론산 겔 및 이의 제조방법
TWI708607B (zh) * 2018-07-06 2020-11-01 南韓商Ｌｇ化學股份有限公司 同時具有高度黏彈性和內聚性之玻尿酸填料
AU2019302833B2 (en) * 2018-07-10 2022-09-22 Lg Chem, Ltd. Hyaluronic acid filler having high lift capacity and low injection force

Also Published As

Publication number Publication date
KR20210114284A (ko) 2021-09-23
CN115279798A (zh) 2022-11-01
EP4119585A1 (en) 2023-01-18
EP4119585A4 (en) 2024-05-15
JP2023518171A (ja) 2023-04-28
WO2021182763A1 (ko) 2021-09-16
JP7480331B2 (ja) 2024-05-09
US20230126726A1 (en) 2023-04-27
KR102395184B1 (ko) 2022-05-10

Similar Documents

Publication Publication Date Title
CO2022010098A2 (es) Inhibidores de proteínas kras mutantes
CO2020010303A2 (es) Conjugados de il-15, y sus usos
CL2021001779A1 (es) Polipéptidos que comprenden polipéptidos con il-2 modificada y usos de los mismos
CL2009000260A1 (es) Antagonista de pcsk9 que comprende un dominio cdr3 de la region variable de la cadena liviana y pesada, el cual inhibe la captacion celular del ldl, composicion farmaceutica que comprende dicho antagonista, uso de este, secuencia nucleotidica que codifica el antagonista, vector y celula huesped que la comprende.
EA201170242A1 (ru) Модифицированные бычьи полипептиды g-csf и их применение
CU20080133A7 (es) Composiciones y métodos de uso para anticuerpos de dickkopf-1
CR20170234A (es) Composiciones de antibiótico
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
CL2022001406A1 (es) Aminoquinolonas sustituidas como inhibidores de dgk alfa para la activación inmune.
BR112022018028A2 (pt) Ácido hialurônico reticulado e composição de carga
CL2021002656A1 (es) Compuestos de pirrolotriazina, inhibidores selectivos de proteínas quinasas kit y pdgfralfa; composición y uso.
MX2021013417A (es) Polipeptidos de union a la proteina del miembro a de la familia 12 del dominio de lectina tipo c (clec12a) y sus usos.
CO2020005625A2 (es) Combinación novedosa de defoliantes
BR112012025066A2 (pt) mistura fluidificante para composição hidráulica
PH12021550289A1 (en) Ox40-binding polypeptides and uses thereof
CO2019008831A2 (es) Composición química
BR112016021898A8 (pt) Modificador de reologia de polímero sintético e substituição de agente de retenção de água para éter de celulose em composições de cimento
BR112022012731A2 (pt) Anticorpo anti-ox40 e uso do mesmo
CL2023000477A1 (es) Proteínas de unión restringidas activadas de forma condicional
CL2023000894A1 (es) Compuestos de heteroarilo fusionados y su uso como inhibidores de camkii
BR112022001336A2 (pt) Anticorpo biespecífico anti-her2/anti-4-1bb e uso do mesmo
CL2012001159A1 (es) Composicion que comprende un inhibidor de alfa-1-proteinasa (api), y como minimo, un aminoacido; kit que comprende dicha composicion que se utiliza como una composicion farmaceutica adecuada para administracion intravenosa.
EP4268901A3 (en) Il-2r beta-gamma c binding compounds and uses thereof
BR112023001471A2 (pt) Composição farmacêutica de anticorpo anti-pd-1 e uso da mesma
ATE543097T1 (de) Zellulärer rezeptor für antiproliferativen faktor

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]